ZEISS may help you identify those patients with glaucoma and then assess their rate of progression for better disease management. Most importantly, ZEISS provides you with complimentary progression data with Structural and Functional analysis, from Gold Standard diagnostic technologies, we deliver: Structural progression analysis (GPA) with Cirrus OCT and Functional progression analysis (GPA) with HFA.
GPA with CIRRUS OCT allows you to simply and easily capture, track and measure progression. Event analysis by CIRRUS differentiates normal change. Trend analysis measures change over time, which can help you understand if more aggressive therapy is required.
GPA with HUMPHREY allows you to quickly and easily compare visual field status and progression to data collected from glaucoma subjects. GPA then uses simple language to help you understand statistically significant change as well as rate of change, and predict future vision quality.